about
Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).Local and systemic innate immune response to secondary human peritonitis.Risk factors for multidrug resistant bacteria and optimization of empirical antibiotic therapy in postoperative peritonitis.The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections.[Diffuse post-operative intra-abdominal sepsis: epidemiological, diagnostic and therapeutic aspects at the General Surgery Service of the University Hospital Aristide Le Dantec in Dakar].Complicated intra-abdominal infections: a focus on appendicitis and diverticulitis.Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.WSES consensus conference: Guidelines for first-line management of intra-abdominal infections.Dynamic changes of microbial flora and therapeutic consequences in persistent peritonitis.Antimicrobial treatment of "complicated" intra-abdominal infections and the new IDSA guidelines ? a commentary and an alternative European approach according to clinical definitions.Impact of abdominal drainage systems on postoperative complication rates following liver transplantationSpectrum adequacy of antibiotic regimens for secondary peritonitis: a retrospective analysis in intermediate and intensive care unit patients.Management of severe sepsis of abdominal origin.Antimicrobial treatment for intra-abdominal infections.Evaluation of human body fluids for the diagnosis of fungal infectionsClinical features and outcome of postoperative peritonitis following bariatric surgery.Factors associated with septic shock and mortality in generalized peritonitis: comparison between community-acquired and postoperative peritonitis.Analysis of current guidelines for intra-abdominal infections.Risk factors for mortality in postoperative peritonitis in critically ill patients.Postoperative peritonitis without an underlying digestive fistula after complete cytoreductive surgery plus HIPEC.Candida peritonitis: an update on the latest research and treatments.Current strategies for the treatment of complicated intraabdominal infections.What's new in the clinical and diagnostic management of invasive candidiasis in critically ill patients.Risk factors for acquisition of multidrug-resistant bacteria in patients with anastomotic leakage after colorectal cancer surgery.The challenge of post-operative peritonitis after gastrointestinal surgery.Ceftazidime-avibactam for the treatment of complicated intra-abdominal infections.Landscape of Resistance-Nodulation-Cell Division (RND)-Type Efflux Pumps in Enterobacter cloacae Complex.Population genetics of the nomenspecies Enterobacter cloacae.Unmet needs in the management of intra-abdominal infections.[Diagnosis and therapy of an acute abdomen].Risk factors for multidrug-resistant bacteria in patients with post-operative peritonitis requiring intensive care.Moxifloxacin for the treatment of patients with complicated intra-abdominal infections (the AIDA Study).Are enterococci playing a role in postoperative peritonitis in critically ill patients?Incidence and outcome of early Candida peritonitis after liver and pancreas transplantation.Prospective, non-interventional, multi-centre trial of tigecycline in the treatment of severely ill patients with complicated infections: new insights into clinical results and treatment practice.Clinical characteristics and prognosis of bacteraemia during postoperative intra-abdominal infections.
P2860
Q26739860-5EC7A057-A55C-4281-A336-6453141C6B6BQ33753759-EAE0E21C-6F9F-4EB0-9F0D-0AF70862A8A5Q33873475-5A005B75-266C-4B57-B672-72F6DB814654Q33892834-3C530C02-0555-4997-99C8-292918A81348Q34081486-EC96B883-B5BD-45F5-B555-2AB8452A4BC1Q34095187-8C7393DF-F504-4B9D-862B-D85B07C970C4Q34505582-A0040A9D-DB6A-47A7-89B9-E133D2FCE5BAQ34541183-94AB2858-9138-47BD-82C7-D659D5CB22E1Q35162610-4AB0281D-DC10-48D8-B0E6-48868CDD3243Q35960005-4DCA732C-8B32-42D0-B553-970D87FBA24CQ35986578-8C6BB528-9F25-46E4-A54A-991778C2AFC3Q36255276-B8E54BB3-B36C-43E2-B274-EFE3D678A592Q36984156-FD2413F9-60CB-4519-BCB9-CE2DF6E20FE0Q37000729-D3FDF4E4-9795-423D-9351-0579EB3BAD4DQ37104973-AACBE8AD-9362-4343-8577-4EEE18E05C60Q37161705-6A129A5B-DFD0-408F-8980-5A1A2F8B191FQ37279923-E00D63E3-1CEE-48A0-8720-D7718BA81A4BQ37557855-05A6234C-11DB-44C0-A3F0-FCA60FAEB7CEQ37628556-A95B3F09-C494-4BA8-8DDC-BEF3EEC9FC13Q37645734-7DEACEF4-5E4C-4C0C-85AC-FDF91D49A803Q37942794-74334BF0-E08C-4B00-8C08-7A6BF272CEC1Q38123247-F26F334A-E8C8-4BCE-8FEA-FB2124CD8EF8Q38203447-052A6724-5C91-46EF-9892-4F044F3A5442Q38367293-96392EA8-8EF8-4415-9416-4639478FF75EQ38564787-7A86F0E0-DD9A-4E03-BEAC-698099E02E2AQ38985065-60F14A35-C248-4AD6-87D2-46D61815118EQ39514434-ACC8C456-BEFA-4448-86F4-7DAE3CF0532CQ39890917-5B6AD3C6-5C6F-416D-8B71-F17B631B05B3Q40079705-0AF33A7C-C4FA-4500-833A-FDABF6B39B1BQ41758690-FABFED08-E1AC-4B02-897A-6A674F6576A4Q43223068-BF50BBDA-E5E5-44E6-AFF0-EDD01C19DAAAQ44526972-25F360E4-16FD-4B03-A490-02D4BE5830FFQ45031561-A93F1E7A-1312-4E38-8C57-753F9F5399A8Q46131346-D7009641-DA9C-4E3C-984A-1F9004E045C0Q54356662-609B7CC8-C799-4FA7-91F5-D1D4C89C8BB7Q55453592-E394E702-ABC5-4FFF-9FB7-65C617D36D64
P2860
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
The microbiology of postoperative peritonitis.
@en
The microbiology of postoperative peritonitis.
@nl
type
label
The microbiology of postoperative peritonitis.
@en
The microbiology of postoperative peritonitis.
@nl
prefLabel
The microbiology of postoperative peritonitis.
@en
The microbiology of postoperative peritonitis.
@nl
P2093
P2860
P356
P1476
The microbiology of postoperative peritonitis.
@en
P2093
Goretzki PE
Roehrborn A
P2860
P304
P356
10.1086/323333
P407
P577
2001-09-24T00:00:00Z